A therosclerosis is a chronic inflammatory disease characterized by accumulation of cholesterol, immune cells, and fibrous elements, leading to formation of atherosclerotic plaques in large and medium-sized arteries. [1] [2] [3] Atherosclerosis-related ischemic symptoms, including acute ischemic stroke and myocardial infarction, are generally thought to result from plaque rupture and thrombosis other than narrowing of the blood vessel lumen. [4] [5] [6] These critical events occur mostly in the presence of unstable atherosclerotic lesions or vulnerable plaques, whereas stable plaques are often asymptomatic throughout a patient's lifetime. 7 The progressive accumulation of inflammatory cells such as macrophages promotes plaque vulnerability by reducing smooth muscle cell (SMC) survival and collagen contents, leading to enlarged unstable plaques covered by thin fibrous caps. 5, 6, [8] [9] [10] Obesity is a known risk factor for atherosclerotic cardiovascular disease, and obesity-associated chronic inflammation has been considered as a major contributor to atherosclerosis development. [11] [12] [13] Many inflammatory signaling pathways that contribute to the pathogenesis of obesity-associated atherosclerosis are regulated by the transcriptional factor NF-jB (nuclear factor jB), a master regulator of the innate and adaptive immune responses.
14-17 Activation of canonical or classical NF-jB signaling by inflammatory mediators requires IKKb (inhibitor of NF-jB kinase b), the predominant catalytic subunit of the IKK complex that mediates the phosphorylation and degradation of the inhibitors of NFjB. 17, 18 Despite numerous studies suggesting the involvement of NF-jB signaling in atherosclerosis development, the tissue or cell type-specific contribution of IKKb-mediated NF-jB activation to atherogenesis has not been completely understood. We and others have recently revealed important new functions of IKKb in atherosclerosis and adipose tissue development. 16, 17, [19] [20] [21] [22] Deficiency of myeloid IKKb, for example, has been shown to reduce macrophage inflammatory responses and to decrease diet-induced atherosclerosis in LDLR (low-density lipoprotein receptor)-deficient (LDLR À/À ) mice. 16 Overexpression of IKKb in liver can aggravate atherosclerosis development in APOE*3-Leiden mice. 19 Deletion of IKKb in SMCs also protected LDLR À/À mice from dietinduced vascular inflammation and atherosclerosis. 17 Deficiency of SMC IKKb has also been shown to affect vascular calcification in another study. 20 Interestingly, we found that many adipocyte precursor cells express SMC markers, and ablation of IKKb in those cells inhibits adipocyte differentiation and renders mice resistant to diet-induced obesity. 17, 21, 23 In addition to adipose progenitors, we generated an adipocytespecific IKKb-deficient mouse model to investigate the impact of adipocyte IKKb expression on adipose tissue development and metabolism. 22 Unexpectedly, adipocyte IKKb-deficient mice have multiple histopathologies in visceral white adipose tissue (WAT) including increased adipocyte death, defective adaptive adipose remodeling, and elevated tissue inflammation when challenged with a high-fat diet (HFD). 22 Mechanistic studies revealed that IKKb is a key adipocyte survival factor, and IKKb can protect adipocytes from HFD-elicited adipocyte death in an obese condition. 22 These findings revealed the complex functions of IKKb signaling in atherosclerosis and adipose tissue development. However, the impact of adipocyte IKKb expression on atherosclerosis development in lean and obese animals has not been investigated.
In the current study, we generated an adipocyte-specific IKKb-deficient LDLR À/À (IKKb DAd LDLR À/À ) mouse model to evaluate the influence of adipocyte IKKb expression on atherosclerosis development under lean and obese conditions. We demonstrate in this study that deficiency of adipocyte IKKb increased atherosclerotic plaque vulnerability without affecting atherosclerotic lesion sizes in HFD-fed LDLR À/À mice, most likely due to increased systemic and lesional inflammation.
Methods
The authors declare that all supporting data are available within the article and its online supplementary files.
Animals
Adipocyte 16, 17, 24, 25 All experimental mice used in this study were male; however, studying a single sex has limitations because sex differences have been widely reported in mouse atherosclerosis studies. 26 Body weight was measured weekly, and body composition was analyzed by EchoMRI (EchoMRI Corp) for measuring the fat and lean masses of mice. On the day of euthanasia, mice were fasted for 6 hours following the dark cycle (feeding cycle), and blood and tissues were then collected as described previously. 16, 25 All animals were housed in an animal facility under a protocol approved by the University of Kentucky institutional animal care and use committee.
Clinical Perspective
What Is New?
• IKKb (inhibitor of NF-jB [nuclear factor jB] kinase b) is a key protein in regulating inflammatory responses.
• Genetic deletion of IKKb in adipocytes did not affect atherosclerotic lesion sizes but increased atherosclerotic plaque vulnerability in obese hyperlipidemic LDLR (lowdensity lipoprotein receptor)-deficient mice.
• In response to feeding with a high-fat diet, IKKb-deficient mice had defective adipose remodeling and increased adipose tissue and systemic inflammation, which likely contributed to the increased plaque inflammation and vulnerability in those mice.
What Are the Clinical Implications?
• Findings from this study suggest that the functions of IKKb signaling in atherosclerosis are complex, and adipose tissue IKKb may affect atherosclerotic plaque stability in an obese condition.
• Analyses of both plaque sizes and stability should be considered for early diagnosis of coronary syndromes in obese patients.
Blood Analysis
Plasma total cholesterol and triglyceride levels were determined enzymatically by a colorimetric method. 16, 27 Lipoprotein fractions were isolated by centrifuging at 189 000g for 3 hours in a Beckman Optima TL-100 tabletop ultracentrifuge at its own density (1.006 g/mL). The infranatant was then adjusted to a density of 1.063 g/mL with solid potassium bromide to harvest the HDL (high-density lipoprotein) fraction by spinning at 189 000g for 18 hours. The cholesterol content of HDL infranatant was measured enzymatically. The cholesterol content of each supernatant and the final infranatant were measured and taken to be VLDL (very low-density lipoprotein; d<1.006 g/mL), LDL (low-density lipoprotein;1.006≤d≤1.063 g/mL), and HDL (d>1.063 g/ mL) cholesterol, respectively. 28 Cholesterol concentrations in all 3 fractions were then determined enzymatically by a colorimetric method. Plasma cytokine levels were also determined by a mouse cytokine multiplex assay kit and a BioPlex 200 system (Bio-Rad Laboratories), as described previously.
22,25
Atherosclerotic Lesion Analysis OCT (optimal cutting temperature compound)-embedded hearts and brachiocephalic arteries were sectioned and stained with Oil Red O, and atherosclerotic lesions were quantified, as described previously. 25, 29, 30 Atherosclerotic Plaque Morphology Histomorphometric Analysis
Atherosclerotic plaques at the aortic root were sectioned, as described previously. 16, 25 Plaque morphological histomorphometric characters were analyzed by hematoxylin and eosin staining. 25 Calcium deposits in aortic root sections were analyzed by alizarin red S staining, as described previously. 31 Plaque composition of lipid-rich cores, collagen, SMCs, and macrophage contents were analyzed by Oil Red O staining, trichrome staining, immunofluorescence staining for a-SMA (a-smooth muscle actin) and CD68, respectively. Plaque stability was evaluated by comparing the ratios of the plaque components mentioned with the entire plaques. The histological plaque stability score was also calculated, as described previously, following the following formula: (plaque stability score)=(SMC area+collagen area)/(macrophage area+lipid area).
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RNA Isolation and Quantitative Polymerase Chain Reaction Analysis
Total RNA was isolated from mouse tissues using TRIZOL Reagent (Life Technologies), and quantitative reverse transcription polymerase chain reaction was performed using gene-specific primers and the SYBR Green PCR Kit (Life Technologies), as described previously. 22, 35, 36 The sequences of the primer sets used in this study are listed in Table. Immunostaining
Immunofluorescence staining of atherosclerotic lesions was performed on 12-lm sections of heart roots freshly embedded in OCT. 16, 17 Sections were first fixed in 4% paraformaldehyde for 15 minutes and then washed with PBS for 20 minutes. Sections were permeabilized with 0.1% Triton X-100 in PBS for 10 minutes. Nonspecific binding was reduced by incubating slides in 10% rabbit sera diluted in PBS for 60 minutes at room temperature. Sections were then incubated with antibodies against CD68 (1:100; MCA1957, Bio-Rad AbD Serotec), rabbit MCP1 (monocyte chemoattractant protein 1; 1:100; ab7202, Abcam), IL-6 (interleukin 6; 1:100; MCA1490, Bio-Rad AbD Serotec), TNF-a (tumor necrosis factor a; 1:100; ab6671, Abcam) or a-SMA (1:100; ab5694, Abcam) 
ICAM1, intercellular adhesion molecule 1; IKKb, inhibitor of NF-jB [nuclear factor jB] kinase b; IL, interleukin; MCP1, monocyte chemoattractant protein 1; TNF-a, tumor necrosis factor a; VCAM1, vascular cell adhesion molecule 1.
at 4°C for 12 to 15 hours. Sections were rinsed with PBS and incubated with fluorescein-labeled secondary antibodies. The nuclei were stained by mounting the slides with DAPI (4 0 ,6-diamidino-2-phenylindole) medium. Images were acquired with Nikon fluorescence microscopy. Immunohistochemical staining of adipose tissue macrophages were performed on 10-lm sections of adipose tissue embedded in paraffin. Rehydrated antigen-retrieved sections were incubated with antibodies against CD68 (1:100; MCA1957, Bio-Rad AbD Serotec) and visualized by the avidin-biotin complex method using the chromogen diaminobenzidine.
Statistical Analysis
Statistical comparisons and analysis were performed using an unpaired 2-tailed Student t test for data normally distributed and the Mann-Whitney test for data not normally distributed. P<0.05 was considered statistically significant. Data are expressed as meanAESEM (for t test) or median and interquartile range (for Mann-Whitney test). The differences of body weight between the 2 groups at different time points were assessed using an unpaired 2-tailed Student t test. Pearson correlation was used to test the interrelationships with body weight at each time point. All statistics were analyzed using GraphPad Prism v8.0 (GraphPad Software). Figure 1A ).
Results
Deficiency of Adipocyte IKKb Does Not Affect Adiposity and Atherosclerosis in Lean LDLR
To determine the role of adipocyte IKKb in atherosclerosis development in a lean condition, 4-week-old male IKKb DAd LDLR À/À and IKKb F/F LDLR À/À littermates were fed a modified semisynthetic low-fat (4.3%) and low-cholesterol (0.02%) AIN76 diet. 37 The modified AIN76 diet has been used successfully in many studies by us and others to induce atherosclerosis in LDLR À/À or APOE (apolipoprotein E)-deficient mice without eliciting obesity and associated metabolic disorders. 28, 29, 37, 38 Consistent with our previous studies on adipocyte IKKb deficiency on C57BL/6 background, 22 deficiency of adipocyte IKKb did not affect body weight, lean and fat mass, and the weight of subWAT, epiWAT, and BAT in lean LDLR À/À mice ( Figure 1B-1D ). In addition, deficiency of adipocyte IKKb did not affect the plasma cholesterol and triglyceride levels in IKKb DAd LDLR À/À mice ( Figure 1E ). Lipoprotein fractions (VLDL, LDL, and HDL) were also isolated, and the cholesterol concentrations in all 3 fractions were measured. 27 The VLDL, LDL and HDL cholesterol levels of IKKb DAd LDLR À/À mice were also comparable with the control littermates ( Figure 1F ). We previously reported an important role of adipocyte IKKb in regulating adaptive adipose remodeling and tissue inflammation in obese mice in responses to HFD feeding. 22 We next sought to determine whether deficiency of adipocyte IKKb affects atherogenesis in obese LDLR À/À mice by feeding them a Western-type HFD for 12 weeks. Consistent with our previous report, 22 deficiency of adipocyte IKKb did not affect total body weight but resulted in partial lipodystrophy and decreased fat mass in obese LDLR À/À mice (Figure 2A and ) and IKKb-deficient LDLR À/À (IKKb DAd LDLR À/À ) mice were fed a high-fat diet for 12 weeks. Representative hematoxylin and eosin staining (A), immunohistochemistry for CD68 (B), and mRNA levels of macrophage markers and proinflammatory cytokines in epiWAT (n=5-7 each group; values are meanAESEM; **P<0.01 and ***P<0.001) (C) and subWAT (n=5-6 each group; values are meanAESEM) (D) of obese IKKb F/F LDLR À/À and IKKb DAd LDLR À/À mice are shown. E, Plasma inflammatory cytokine levels were also measured (n=7-10 each group; values are median and interquartile range; *P<0.05, **P<0.01 and ***P<0.001). Scale bars=200 lm. EpiWAT indicates epididymal white adipose tissue; IFN-c, interferon c; IL, interleukin; MCP1, monocyte chemoattractant protein 1; subWAT, subcutaneous white adipose tissue; TNF-a, tumor necrosis factor a. not affect macrophage infiltration ( Figure 3B ) and inflammatory gene expression ( Figure 3D ) in subWAT of IKKb DAd LDLR À/À mice. In addition to subWAT and epiWAT, we measured the expression levels of several key cytokines and adipokines in periaortic adipose tissue and found that deficiency of IKKb did not significantly affect the expression levels of these genes ( Figure S2 ).
To determine whether deficiency of IKKb may affect systemic inflammation in obese IKKb
DAd LDLR À/À mice, we measured the plasma cytokine levels. As shown in Figure 3E , the plasma levels of several proinflammatory cytokines including MCP1 and TNF-a were also significantly increased in IKKb DAd LDLR À/À mice compared with IKKb F/F LDLR À/À littermates ( Figure 3E) Figure 4A and 4B ). In addition, deficiency of adipocyte IKKb did not affect necrotic core areas in atherosclerotic lesions at the aortic root of obese LDLR À/À mice ( Figure 4C ). As expected, both IKKb DAd LDLR À/À and IKKb F/F LDLR À/À mice had diet-induced hyperlipidemia, and adipocyte IKKb deletion did not alter plasma total cholesterol and triglyceride levels ( Figure 4D ) or VLDL, LDL, and HDL cholesterol levels ( Figure 4E ). Thus, deficiency of adipocyte IKKb did not affect plasma lipid levels and atherosclerotic lesion sizes in obese LDLR À/À mice after HFD feeding.
Ablation of Adipocyte IKKb Increases Atherosclerotic Lesional Inflammation and Plaque Vulnerability in Obese LDLR À/À Mice
Despite the unchanged atherosclerotic lesion size, the expression levels of several key proinflammatory proteins, including MCP1, TNF-a, and IL-6, were significantly increased in both atherosclerotic lesions and vessel walls at the aortic root of IKKb DAd LDLR À/À mice, as indicated by immunofluorescent staining ( Figure 5A-5C Figure 5D ). We next sought to determine whether the enhanced inflammation affected atherosclerotic plaque stability. The phenotypic characteristics of vulnerable plaques include increased lipid-rich necrotic core size, decreased thickness of the fibrous cap, decreased plaque collagen and SMC contents, and increased macrophage contents, all of which have been used as indicators of plaque vulnerability.
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Immunostaining for macrophage and SMC markers showed that macrophage contents were increased but SMC contents were decreased in the lesions of IKKb DAd LDLR À/À mice compared with IKKb Furthermore, trichrome staining showed that deficiency of adipocyte IKKb decreased collagen contents in the atherosclerotic lesions of IKKb DAd LDLR À/À mice ( Figure 6C ).
The contents of macrophages, SMCs, and collagens in the atherosclerotic lesions were also quantified, which confirmed the significant altered lesional contents in IKKb DAd LDLR À/À mice ( Figure 6D ). Based on these quantification data, the histological plaque stability scores were then calculated and confirmed that adipocyte IKKb deficiency led to significantly decreased plaque stability scores in obese LDLR À/À mice ( Figure 6E ). In addition, we evaluated plaque calcification by alizarin red S staining, which has been associated with plaque vulnerability and an increased risk of rupture. Interestingly, deficiency of adipocyte IKKb also resulted in increased calcification in the lesions of IKKb DAd LDLR À/À mice (Figure S3) . Collectively, these results demonstrated increased atherosclerotic lesional inflammation and plaque vulnerability in obese IKKb DAd LDLR À/À mice.
Discussion
The role of IKKb-mediated NF-jB signaling in the regulation of inflammation and immune responses has been well defined, 15, 18, 39, 40 and IKKb has been considered a key molecular link between obesity and metabolic diseases. 15 Adipocytes are not only simple energy-storing cells but also secretory cells that produce proinflammatory cytokines and adipokines. 15 Many of these proinflammatory factors, including MCP1, IL-6, and TNF-a, which are regulated by IKKb/NF-jB signaling, have been known to contribute to atherosclerosis development. As a central coordinator of inflammatory responses through activation of NF-jB, IKKb has also been implicated in the pathogenesis of atherosclerosis in humans and animal models. 15, 51 IKKb-dependent NFjB activation, for example, has been identified in human atherosclerotic plaques and was enhanced in unstable coronary plaques. 52, 53 Animal studies have suggested that deficiency of IKKb or inhibition of NF-jB activation in macrophages, SMCs, and endothelial cells resulted in decreased cellular inflammatory responses and atherosclerosis development. 16, 17, 54 However, the functions of adipose tissue IKKb signaling in obesity and obesity-associated metabolic disorders are complex. Previous studies have investigated the role of IKKb/NF-jB signaling in adipose tissue by overexpressing p65 or a constitutively active form of IKKb in adipose tissue. 50, 55 As expected, these transgenic mice had increased adipose tissue inflammation. 50, 55 Paradoxically, these mice were also resistant to diet-induced obesity and insulin resistance. 50, 55 We recently demonstrated that IKKb functions in both adipocyte precursor cells and mature adipocytes to regulate adipose tissue expansion and remodeling in diet-induced obesity. 17, 21, 22 Although IKKb signaling in adipocyte precursor cells promotes the differentiation of those cells into mature adipocytes, 17, 21, 23 IKKb is also required for mature adipocyte survival and proper adipose tissue remodeling in diet-induced obesity. 22 IKKb DAd mice that we previously generated had abnormal visceral adipose tissue characterized by marked heterogeneity in adipocyte sizes, increased adipocyte death, and accentuated inflammatory responses when challenged with an HFD. 22 Consistent with our results, another group demonstrated that deficiency of adipocyte IKKb led to visceral adipose tissue inflammation under an HFD feeding condition. 49 Our mechanistic studies then revealed that IKKb protects adipocytes from HFD-induced cell death; therefore, IKKb is a key survival factor that protects adipocytes against cell death in response to HFD stress challenges. 22 In the current study, magnitude of the increased inflammation was not strong enough to constitute a major impact on the atherosclerotic lesion growth under our current feeding condition (12 weeks of HFD feeding for 4-week-old mice). It is also possible that a deficiency of adipocyte IKKb may affect lesion sizes in advanced atherosclerosis in response to prolonged HFD feeding. In addition to contributing to atherosclerotic lesion growth, inflammation may affect atherosclerotic plaque stability, plaque rupture, and thrombosis. 5, 6, 8, 9, 56 Accumulating evidence indicates that the major atherosclerosis complication is the rupture of atherosclerotic plaque, 57 and stabilizing plaque has become an important topic for atherosclerosis treatment. Atherosclerotic lesion composition rather than size has also been used to determine the plaque propensity that causes thrombotic complications. 58 Moreover, clinical studies have demonstrated that identification of high-risk unstable plaques (with morphological features of large necrotic core, higher macrophage count, positive remodeling, speckled calcium, and thin fibrous cap) on coronary imaging improves early diagnosis of acute coronary syndromes. 59, 60 Inflammation can also promote the destabilization and rupture of atherosclerotic plaques by enhancing collagen degradation and macrophage recruitment and decreasing collagen synthesis. 
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